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Lactoferrin has for long captured the interest of many researchers as a natural compound with a wide
variety of uses. Lactoferrin is a monomeric, iron-binding 80 kDa glycoprotein, and appears to be the
subfraction of whey with the best documented antiviral, antimicrobial, anticancer and immune
modulating/enhancing effects. It belongs to the family of transferrin proteins, and serves to control iron
levels in body ﬂuids by sequestering and solubilizing ferric iron. In the present research effort,
production of lactoferrin derivatives (starting from a puriﬁed commercial extract), encompassing full
stabilization of its three-dimensional structure, has been attempted via nanoencapsulation within lipid
nanovesicles, integrating a multiple water-in-oil-in-water emulsion. Long-term storage of the multiple
nanoemulsions produced did not lead to leaching of protein, thus proving the effectiveness of the
encapsulation procedure. Furthermore, lactoferrin nanovesicle derivatives prepared under optimal
conditions were successfully employed at lab-scale antimicrobial trials.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Lactoferrin is an iron transporter, glycoprotein, isolated from
bovinemilk, constituting aminor component ofwhey proteins. This
protein is composed of 703 aminoacids and has a molecular weight
of ca. 80 kDa (Hoek, Milne, Grieve, Dionysius, & Smith, 1997).
Lactoferrin is considered a multifunctional protein, playing several
biological roles. Due to its iron-binding properties, lactoferrin
potentially plays a role in ironuptake by the intestinalmucosa of the
suckling neonate, hence making it a potential source of iron for
breast-fed infants. On the other hand, lactoferrin has been shown
to have antibacterial, antiviral, antifungal, anti-inﬂammatory,
antioxidant and immunomodulatory activities (Hoek et al., 1997;
Orsi, 2004; Rodríguez-Franco, Vásquez-Moreno, & Montfort, 2005;
Takakura et al., 2003; Ward, Uribe-Luna, & Conneely, 2002;
Yamauchi, Tomita, Giehl, & Ellison, 1993). Lactoferrin can show alopment and Evaluation of
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All rights reserved.direct bactericidal activity due to its binding to the lipid A part of
bacterial lipopolyssacharide, with an associated increase in mem-
brane permeability, an action that is due to lactoferricin, a peptide
obtained from lactoferrin by enzymatic cleavage,which is active not
only against bacteria, but even against fungi, protozoa and viruses
(Orsi, 2004). Bovine lactoferrin, extracted from whey proteins, is
marketed as a nutritional supplement, but has a high potential for
biopharmaceutical applications. However, as most proteins or en-
zymes, it is fragile, and even small conformational changes may
reduce its activity, and therefore stabilisation is required. One pos-
sibility is to encapsulate the protein into nanometre-sized vesicles
to protect the bioactive protein from denaturation by proteolysis
and dilution effects. The development of strategies that may permit
structural and functional stabilization of lactoferrin via nano-
encapsulation may increase the biopharmaceutical applicability of
this bioactive protein (Srinivas et al., 2010). Such lactoferrin-
encasing nanovesicles could be utilized, e.g. in the formulation of
dental elixirs to eliminate the oral microﬂora responsible for for-
mation of oral bioﬁlms with one clear advantage: the adhesive
nanovesicles could slowly liberate its naturally antimicrobial con-
tent, thus reducing the development of dental cavities. Oral delivery
of proteins has been long identiﬁed as one of themain challenges in
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García-Fuentes, Torres, & Alonso, 2002; Lee & Yuk, 2007; Reis,
Neufeld, Ribeiro, & Veiga, 2006a; Sanjula, Shah, Javed, & Alka,
2009), since in addition to its great technological potential, impor-
tant drawbacks for its development still exist (Yang, Yuan, & Jin,
2009). Currently, the number of drugs based on large biological
molecules, such as proteins and peptides, is drastically increasing
(Reis, Neufeld, Ribeiro, & Veiga, 2006b). However, various factors,
including stability and circulation time in the gastrointestinal tract,
can strongly affect the effective absorption of oral-delivered pro-
teins (Dupeyrón, Rieumont, González, & Castaño, 2009).
Lipid-based carriers have attracted increasing scientiﬁc and
commercial attention during the last few years as alternative ma-
terials for the delivery of peptides and proteins concerned with
stability issues (Acosta, 2009; Chakraborty, Shukla, Mishra, & Singh,
2009; Rawat, Singh, Saraf, & Saraf, 2008). Recently, a newly devel-
oped technique for stabilization of proteins and enzymes based on
nanoencapsulation procedures has started to gain momentum,
based on encapsulation of macromolecules in a nanoporous matrix
by the gelation of a solution (Erdinc, 2007, pp. 90; Ferrer, Yuste,
Rojo, & del Monte, 2003; Ragoonanan & Aksan, 2007). Due to be-
ing entrapped in a very conﬁned environment (i.e. in the nano-
pores), the molecular motions of water molecules are altered,
slowing down. Therefore, conﬁnement of proteins and/or peptides
within nanoporous matrices (or coatings) has the same effect as the
osmolytes with respect to changing thewater activity and therefore
modifying the biochemical reaction rates. Due to increased vis-
cosity and entropic conﬁnement (physical entrapment), the
(degradation) reaction rates are slowed down and the biological
materials can be stabilized for storage (Mozafari et al., 2008;
Ragoonanan & Aksan, 2007). Water-in-oil-in-water (W/O/W)
emulsions are examples of multiple emulsions, in which disper-
sions of small water droplets within larger oil droplets are them-
selves dispersed in a continuous aqueous phase (Bibette, Calderon,
& Poulin, 1999; Dupeyrón et al., 2009; Ficheux, Bonakdar, Leal-
Calderon, & Bibette, 1998; García-Fuentes et al., 2002; Hanson
et al., 2008; Wang, Tao, & Gang, 2006). Emulsions are quite uti-
lized in many ways of processing, and are extensively used by the
food, cosmetic, and coating industries. Due to their compartmen-
talized internal structure, multiple emulsions present advantages
over simple oil-in-water (O/W) emulsions for encapsulation, such
as the ability to carry both polar and non-polar molecules, and a
better control over releasing of therapeutic molecules (Davis &
Walker, 1987; Marcato & Durán, 2008; Okochi & Nakano, 2000;
Pays, Giermanska-Kahn, Pouligny, Bibette, & Leal-Calderon, 2002).
In the present research work, the potential of natural antimicrobial,
bovine lactoferrin, stabilized via nanoencapsulation for incorpora-
tion in a mouth wash elixir has been investigated. Bovine lacto-
ferrin was entrapped within W/O/W multiple nanoemulsions,
aiming at mimicking the multifunctional design of biological
membranes, with several lipid matrices, and stabilizing layer
compositions. The composition of the stabilizing layer of the
nanosystemwas changed by using different proportions of lecithin
and different poloxamers (nonionic triblock copolymers with a
central hydrophobic core of polyoxypropylene ﬂanked by two hy-
drophilic chains of polyoxyethylene), thus allowing to control
degradation times of the nanovesicles. For the production of
nanoemulsions, bioactive compounds were previously dissolved in
the aqueous phase prior to be dispersed in the melted lipid during
homogenization in an UltraTurrax (model T25D from IKA) under
heating (ca. 40 C). The resulting nanoemulsions were subse-
quently fully characterized physicochemically. Characterization of
the optimized nanovesicle formulations encasing the bioactive
lactoferrin encompassed determination of particle size, size dis-
tribution and particle charge, via Zeta potential analysis, surfacemorphology via Scanning Electron Microscopy (SEM), and thermal
analysis via Differential Scanning Calorimetry (DSC). The antimi-
crobial activity of the nanoemulsions was also assessed in vitro,
upon several microbial strains in liquid medium, including patho-
genic bacteria and Candida albicans.
2. Materials and methods
2.1. Materials
2.1.1. Bioactive protein
The bioactive lactoferrin used consisted of a puriﬁed extract
(protein content of 96.0%, of which lactoferrin accounts for 98.0%)
from bovine whey, and was kindly supplied by DMV International
(Delhi NY, USA).
2.1.2. Chemicals
Softisan 100 was purchased from Sasol (Sasol Oleﬁns & Sur-
factants GmbH, Hamburg, Germany). Precirol ATO5 (glycerol dis-
tearate) and Compritol 888ATO (glycerol dibehenate) were kindly
supplied from Gattefossé SAS (Saint Priest, France). Glycerol
(anhydrous) was purchased from Fluka (Steinheim, Germany).
Surfactants: Tween 80 was purchased from SigmaeAldrich (St.
Louis MO, USA). Lutrol F68 (poloxamer 188) and Lutrol F127
were kindly supplied by BASF ChemTrade GmbH (Ludwigshafen,
Germany).Other chemicals: CaCl2$2H2Owas obtained fromRiedel-
de-Haën (Seelze, Germany. Commercial HCl (37%) and NaCl were
purchased from Vaz Pereira (Lisbon, Portugal). Soybean phospha-
tidylcholine (lecithin) was purchased from Acofarma (Barcelona,
Spain). Filter paper (0.22 mm) was purchased from Nalgene (New
York NY, USA), and nonsterile ﬁlters (0.45 mm)were purchased from
Nucleopore (Cambridge MA, USA). Tap water was puriﬁed in a
Milli-Q Plus 185 system (Molsheim, France) to a ﬁnal conductivity
of ca. 18.2 MU cm1. The solvents used were all analytical grade or
better, and were used without further puriﬁcation.
2.1.3. Analytical equipment
All spectrophotometric readings were carried out using quartz
cuvettes in an UVeVIS spectrophotometer from Shimadzu (Kyoto,
Japan). The Zeta Potential and Hydrodynamic Size of the nano-
emulsion particles were determined in a Zetasizer (model Nanos-
eries Nano-ZS) from Malvern Instruments Ltd (Worcestershire,
United Kingdom). Calorimetric studies were carried out in a dif-
ferential scanning calorimeter (Shimadzu, Kyoto, Japan), which
comprised a detector (DSC-50) and a thermal analyser (TA-501).
Cryo-SEM analysis of lipid nanoemulsions were carried out in a
Scanning Electron Microscope from JEOL (model JSM 6301F from
JEOL, Tokyo, Japan), coupled with an Ion Sputter-Coater JSC1100
(JEOL, Tokyo, Japan), an INCA 350 Energy X-Ray microanalysis
systemvia Energy Dispersive Spectrometry (SEM/EDS) fromOxford
Instrument GmbH (Wiesbaden, Germany), and a cryo transfer
system from Gatan Inc. (model Alto 2500 from Gatan Inc, Pleas-
anton CA, USA).
2.2. Experimental procedures
2.2.1. Preparation of multiple lactoferrin-encasing nanoemulsions
Production of multiple nanoemulsions (water-in-oil-in-water,
W/O/W) with nanoencapsulated lactoferrin were carried out in
duplicate in an UltraTurrax (model T25D from IKA) under heating
(ca. 40 C), with the bioactive lactoferrin being previously dissolved
in the (inner) aqueous phase (W) prior to being dispersed in the
melted lipid (O) (Softisan) during homogenization (10 min at
8000 rpm). Therefore, ﬁnal W/O/W dispersions of lactoferrin were
obtained via sequential (optimized) homogenization of a W/O
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phase was constituted by HCl 10 mM, CaCl2 20 mM, Tween 80 and
pure bovine lactoferrin (with concentrations ranging from 2.5 mg/
mL to 25 mg/mL); the intermediate oily phase encompassed glyc-
erol, Softisan (or Precirol or Compritol) and soybean phosphati-
dylcholine; ﬁnally, the outer aqueous phase encompassed Lutrol
F68 (or Lutrol F127), ultrapure water and NaCl 10 mM. Control
nanoparticles were also produced, without lactoferrin, and stored
for 52 days under the same conditions. The solid lipids were tested
as possible constituents of the oily phase. All these agents are
considered to be lipids for modiﬁed release formulations. The for-
mulations prepared with each of these lipids showed a milky and
uniform appearance.
2.2.2. Evaluation of the combined effects of homogenization time,
lactoferrin concentration and ionic strength of the outer aqueous
phase, for optimization of the nanoformulation
Stability of the multiple nanoemulsions was evaluated by pro-
ducing emulsions as result of the combined effect of homogeniza-
tion time (5, 10 and 20 min), lactoferrin concentration (2.5, 5.0, 10.0
and 25.0 mg/mL) and ionic strength (NaCl 1, 10 and 100 mM) of the
aqueous outer phase.
2.2.3. Determination of hydrodynamic size and Zeta potential
Zeta potential is the electric potential that prevails in the cutting
plan of a particle, which is at a small distance from its surface, and
which results from the measure of the mobility distribution of a
dispersion of charged particles as they are subject to an electric
ﬁeld. The mobility can be deﬁned as the velocity of a particle per
unit electric ﬁeld, and is determined by applying an electric ﬁeld to
the dispersion of particles and measuring their average velocity.
The results obtained (in duplicate) allow determination of the hy-
drodynamic size of the lipid nanovesicles, of the polydispersion
index and of their Zeta potential.
2.2.4. Thermal analysis by differential scanning calorimetry (DSC)
For every calorimetric assay, ca. 10 mg of (nano)emulsion were
weighed (using a microsyringe) directly into the interior of high-
pressure aluminium pans (Shimadzu, P/N 557 201-53090,
64U3670609), and duly sealed by pressure. A reference aluminium
pan was also prepared by simply sealing air inside an empty case.
The samples were then heated from room temperature to 100 C at
a constant linear scanning rate of 5 C min1, during which the
amount of heat absorbed by the samples was recorded.
2.2.5. Antimicrobial activity of lactoferrin and multiple
nanoemulsions
Screening of antimicrobial activity was determined by the
diffusion method. Inocula of each target microorganism e Staphy-
lococcus aureus, Salmonella sp., Escherichia coli, Pseudomonas aeru-
ginosa, Listeria innocua, Bacillus cereus, and C. albicans e were
prepared by suspension of a pure colony in 0.9% sterile NaCl (to
reach a standard turbidimetry of 0.5 McFarland). Each suspension
was inoculated in Mueller Hinton Agar, and after drying, separated
wells were made in the plates, and 60 mL of different nanoemulsion
samples and controls were added. Sterile water was used as
negative control, and antibiotics as positive controls (chloram-
phenicol for S. aureus, Salmonella sp., E. coli, P. aeruginosa, and
B. cereus and ampicillin for L. innocua). Each plate was incubated at
37 C for 24 h, after which the inhibition halos were measured. In
the case of pure lactoferrin and nanoemulsion samples with anti-
microbial activity, Minimum Inhibitory Concentration (MIC) was
determined bymicroplate assay, using same targetmicroorganisms
and inocula as described previously. Each suspension of microor-
ganismwas inoculated in 96-well plates containing Mueller HintonBroth for bacteria and Yeast Malt Broth for yeast, with different
lactoferrin concentrations (2000, 1000, 500, 250, 200, 125,
62.5 mg mL1). Sterile water was used as negative control and un-
inoculated media were used as a positive control. The plates were
incubated at 37 C for 24 h, and optical density was measured by
plate reader at 620 nm. The MIC was determined as the lowest
concentration of lactoferrin (free or in nanoemulsion) that showed
absence of turbidimetry when compared with the positive control.
2.2.6. (Cryo-) scanning electron microscopy analyses
Lipid nanoemulsions encasing lactoferrin were analysed for
microstructural and morphological characteristics via Cryo-SEM.
Brieﬂy, lactoferrin-encasing nanoemulsion samples were pre-
pared for analysis as follows: (i) samples were mounted in an
appropriate (aluminium) support inserted into a gold-coated plate;
(ii) the gold-coated plate was then duly ﬁxed in a transfer stick; (iii)
the support containing the sample was immersed in liquid (slush)
nitrogen; (iv) the sample was then transferred under vacuum into
the SEM preparation chamber (also under vacuum and maintained
cold via addition of liquid nitrogen); (v) inside the chamber, the
deep-frozen sample was fractured, undergone sublimation (during
90 se300 s) by gently increasing the temperature from 140 C to
ca. 90 C, and was sputter-coated with 100e200 A of Au/Pd
(during 20 s) in a strong vacuum (0.5 atm) between 20 and 30 mA
at 2.5 kV; (vi) ﬁnally, the sample was transferred into the SEM
chamber for microscopy analysis. The samples were analysed at
CEMUP (Centro de Materiais da Universidade do Porto) with a
scanning electronmicroscope from JEOL operating at 5e15 kV, with
an incidence angle of 30, coupled with X-Raymicroanalysis. A cryo
transfer system for SEM analysis was used for all sample transfer
prior to SEM analysis.
3. Results and discussion
3.1. (Cryo-) scanning electron microscopy
Magniﬁcations of pure lactoferrin powder of 400 and of
lactoferrin-encasing nanoemulsions of 15,000 and 50,000 are
depicted in Fig. 1aec, respectively. The cryo scanning electron mi-
crophotographs of the exposed (fractured) surface of lactoferrin-
encasing nanoemulsions (see Fig. 1b and c) show the poloxamer
matrix structure developed during the manufacturing process and
the highly homogeneous distribution of nanovesicle diameters.
3.2. Optimization of the formulation
For producing an optimal nanoformulation, several variables
were studied, viz. lipid nature, poloxamer concentration, soy leci-
thin concentration, homogenization time, and lactoferrin concen-
tration (see Table 1). (Puriﬁed) buffered lactoferrin was found to be
more stable than unbuffered lactoferrin. Centrifugation of the
optimized nanoformulations did not lead to any lactoferrin liber-
ation induced by bursting nanovesicles (as revealed by UVeVIS
spectrophotometry), thus evidencing the ﬁrm encapsulation and
concomitant structural stabilization of lactoferrin. Increasing lac-
toferrin concentration led to an increase in the values of Zeta po-
tential (from negative towards positive values). Addition of an
electrolyte (sodium chloride) to the external aqueous phase also led
to an increase in the values of Zeta potential (see Fig. 2), presumably
due to accumulation of adsorbed ions at the particle surfaces.
However, when using a higher (100 mM) electrolyte concentration,
phase separationwas notorious immediately after homogenization.
Addition of electrolyte at concentrations of 10 mM proved to be
most suitable, by producing nanovesicles with (more) stable Zeta
potential values over time.
Fig. 1. Scanning electron microscopy analysis of the lactoferrin lyophilizate using 400
magniﬁcation (a) and cryo-scanning electron microphotographs of lactoferrin-
encasing nanoemulsions, showing the poloxamer network in the outer aqueous
phase after sublimation and sputter coating with gold/palladium, for 15,000
magniﬁcation (b) and 50,000 magniﬁcation (c).
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The net charge at the surface of particles in suspension affects
the ionic distribution in their immediate surroundings, producing
an electrical double layer around each particle. When a particle
moves, the ions within the boundary move with it, and vice versa.
Zeta potential is the potential that exists at this boundary, and its
intensity is an indication of the potential stability in the colloidal
system, and can be measured by determination of the linear
velocity of the particles in an electric ﬁeld. The Zeta potential
depends on the concentration of ions in the solvent. The mainreasonwhy tomeasure the Zeta potential lies in predicting colloidal
stability, which in turn depends on the interactions between par-
ticles. Zeta potential is therefore an attempt to quantify such in-
teractions, by predicting stability. The Zeta potential is a measure of
the repulsive forces between particles, and since the majority of
colloidal aqueous systems is stabilized via electrostatic repulsion,
the larger the repulsive forces between particles the smaller the
probability for them to become closer and form aggregates, leading
to a more stable colloidal system. The mean size and size distri-
bution (polydispersity index) were measured in duplicate samples
via Dynamic Laser light Scattering (suitable for particles ranging
from 5 nm to ca. 3 mm), and the results presented as the mean
values. Optimum homogenization time was found to be 10 min, at
8000 rpm, since during such homogenization timeframe the par-
ticle sizewasmaintained at values ranging from 100 to 200 nm (see
Figs. 2 and 3). Storage of the optimized multiple nanoemulsions
(produced with Softisan) throughout 50 days at room temperature
led to an increase in the values of Zeta potential, presumably due to
ion concentration at particle interface (see Fig. 2). Control nano-
particles were also produced, without lactoferrin, and stored for 52
days under the same conditions; for these, a slight increase in
particle size was noticed, together with a slight increase in Zeta
potential values. Regarding particle size, no changewas observed in
the range of 100e200 nm. Precirol and Compritol were also
tested as lipids for the oily phase, but owing to their high(er)
melting points, were discarded in order to prevent deactivation of
lactoferrin (see Fig. 2). Lecithin and Tween 80 were selected as
suitable excipients, since even at duplicate amounts the Zeta po-
tential values were maintained at lower (negative) values at the
same time that hydrodynamic size did not suffer any signiﬁcative
changes over time (see Fig. 2). Increasing electrolyte concentration
leads to an increase in the values of Zeta potential, presumably due
to accumulation of adsorbed ions at the particle surfaces. Addition
of electrolyte at concentrations of 10 mM proved to be most suit-
able by producing nanovesicles with stable Zeta potential over
time. Storage of the optimized multiple nanoemulsions (with Sof-
tisan, due to its mild melting temperature) throughout several days
at room temperature led to an increase in Zeta potential values (see
Fig. 4), presumably due to ion concentration at particle interface.
3.4. Antimicrobial activity
Probably, the best known role of lactoferrin is as an iron-binding
protein, as it is known to have an extremely high afﬁnity for this
metal. Many pathogenic bacteria need a supply of free iron to
multiply and in the presence of lactoferrin are strongly inhibited or
killed. The antimicrobial activity of the different nanoemulsions,
assessed in vitro against several microbial strains showed different
efﬁciency depending on the pathogenic microorganism. The anti-
microbial activity of both free and encapsulated lactoferrin was
validated through in vitro procedures against several microbial
strains, including pathogenic bacteria and yeast C. albicans. The
results showed that the MIC of both free and encapsulated lacto-
ferrin upon the bacteria S. aureus and L. inoccuawas 2000 mg mL1
while that for B. cereuswas higher than 2000 mgmL1. In the case of
yeast C. albicans, it was susceptible to lower concentrations of lac-
toferrin, since the MIC was 200 mg mL1. The results were similar to
both free and encapsulated lactoferrin, in the same concentration
basis. It has been demonstrated (Ellison, Giehl, & LaForce,1988) that
lactoferrin interacts with Gram negative bacteria leading to the
release of signiﬁcant levels of lipopolysaccharide from the outer
membrane, compromising the outer membrane permeability and
increasing bacterial susceptibility to other antimicrobial molecules
such as lysozyme. In the research effort entertained herein, lacto-
ferrin did not exhibit any antimicrobial activity upon Gram negative
Table 1
Optimization of processing conditions leading to an optimal nanoformulation.
Formulation parameters Composition of the several nanoformulations (w/w)
Designed starting
conditions
Without lactoferrin
(control)
With lactoferrin
and NaCl
With lactoferrin,
NaCl and CaCl2
With 25% more of
lecithin and tween 80
With 50% more lecithin
and Tween 80
Homogenization speed (rpm) 8000 8000 8000 8000 8000 8000 Best formulation
achievedInternal aqueous
phase
Lactoferrin 0.05% 0.00% 0.05% 0.05% 0.05% 0.05%
HCl (0.010 M) 9.80% 9.80% 9.79% 9.79% 9.79% 9.78%
CaCl2 (0.020 M) 0.00% 0.00% 0.00% 0.03% 0.03% 0.03%
Tween 80 0.10% 0.10% 0.10% 0.10% 0.12% 0.15%
Oil phase Lipid 0.98% 0.98% 0.98% 0.98% 0.98% 0.98%
Soybean lecithin 0.10% 0.10% 0.10% 0.10% 0.12% 0.15%
Glycerol 9.80% 9.80% 9.79% 9.79% 9.79% 9.78%
External aqueous
phase
Poloxamer
(Lutrol F68)
0.78% 0.78% 0.78% 0.78% 0.78% 0.78%
Ultrapure H2O 78.39% 78.44% 78.36% 78.32% 78.29% 78.25%
NaCl (0.010 M) 0.00% 0.00% 0.05% 0.05% 0.05% 0.05%
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were not inhibited, but as mentioned above it may have destabi-
lized their outer membrane.
3.5. Microcalorimetric analysis
Differential scanning calorimetric measurements provided an
insight into the state and degree of crystallinity, and the melting
and crystallization behaviour of crystalline materials such as the
lipid nanovesicles produced. The amount of heat absorbed by the
lipid nanovesicles was the same when comparing empty vesicles
and vesicles incorporating lactoferrin, for an (optimized) homoge-
nization period of 10 min (see Fig. 5). Also, increasing homogeni-
zation time led to nanovesicles that exhibited an increase in the
amount of heat absorbed by the particles, probably due to a
reduction in size and/or to liberation of lactoferrin (see Figs. 3 and
5). The effect of homogenization time was very notorious in the
amount of heat absorbed (melting enthalpy) by the lipid nano-
formulation encasing lactoferrin: 75.48 J g1nanoemulsion for 5 min
homogenization time (absorption peak at 91.70 C),
245.04 J g1nanoemulsion for 10 min homogenization time (absorption
peak at 87.64 C), and 866.64 J g1nanoemulsion for 20 min homogeni-
zation time (absorption peak at 86.03 C). IncreasingFig. 2. Effect of storage time upon hydrodynamic size and Zeta potential of
nanovesicles produced with several (different) lipids, for optimized homogenization
timeframe (10 min).homogenization time led to production of nanovesicles that
exhibited an increase in the amount of heat absorbed by the par-
ticles, probably due to a reduction in size and/or to liberation of
lactoferrin (see Fig. 5). A blank (empty) nanoemulsion, prepared
without lactoferrin under the same experimental conditions,
absorbed 1450 J g1nanoemulsion for 10 min homogenization time
(absorption peak at 87.54 C), a value that is 6 times higher than
that of the same nanoemulsion encasing lactoferrin. Inclusion of
lactoferrin in the nanoformulation did not lead to signiﬁcative
changes in the peak of heat absorption (87.64 C), when compared
with the blank (empty) counterpart (87.54 C), but for the same
homogenization timeframe the amount of heat absorbed was sig-
niﬁcatively lower. Lactoferrin alone in ultrapure water showed a
melting enthalpy of 878.79 J g1nanoemulsion, at a temperature peak of
69.97 C, a value clearly higher than that of the nanoemulsion
encasing lactoferrin after 10 min of homogenization, which prob-
ably accounts for the stabilizing effect of the nanoencapsulation
procedure. Macroscopic observations of optimized nanosystems
with increased amount of the semicrystalline polymer (Tween 80,
i.e. poly(oxyethylene) sorbitan monooleate) showed no visible
phase separation, and absence of adherence to the container walls
even after a prolonged storage at room temperature. The optimized
nanosystem encompassed nanovesicles with an average size of ca.
100e200 nm and an average Zeta Potential of ca. 14.6 mV (see
Figs. 2 and 4), which were maintained stable over a storageFig. 3. Effect of homogenization time in the hydrodynamic size of the nanovesicles
produced throughout storage time.
Fig. 4. Effect of different excipients in the Zeta potential of the nanovesicles using
Softisan for 10 min homogenization time.
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amounts of Tween 80 and other components of internal aqueous
phase can be attributed to hydrogen bonding and to the lower
crystalline lattice energy of this polymer, which had a notorious
impact in the melting proﬁle of the optimized nanoemulsion. In
water-in-oil emulsions (such as our nanovesicles), there is a posi-
tive correlation between emulsion stability and fatty acid chain
length and a negative correlationwith the dielectric constant of the
emulsiﬁer. Increasing molecular weight (such as in Softisan 100,
with C10eC18 fatty acidmoieties) and decreasing dielectric constant
(such as in Tween 80) indicates greater hydrophobicity, leading to a
greater impregnation of the interface and to a more stable (nano)
emulsion, which is in clear agreement with the long-term stability
observed for our multiple nanoemulsion systems. Additionally,
imprisonment of a protein molecule leads to thermodynamic sta-
bility, which can be correlatedwith a change in the thermodynamic
conditions of the microenvironment surrounding each molecule,
since the movements of (aqueous) solvent molecules in their
microneighborhood become seriously reduced by the effect of be-
ing containedwithin thematrix’s core. The result is that the protein
entity’s rotational, translational and vibrational viscosity becomes
enhanced, leading to a more rigid three-dimensional architecture
with concomitant decrease of entropy and producing stabilization
of the biomolecule.Fig. 5. Differential scanning calorimetry thermograms of multiple nanoemulsions
produced during several homogenization times, with and without lactoferrin.4. Conclusions
In this research effort, development and optimization of lipid
nanovesicles encasing lactoferrin was pursued. A lipid with mild
melting temperature was found most appropriate for the discon-
tinuous oily phase. A homogenisation timeframe of 10 min, the use
of an electrolyte with a low ionic strength, and low lactoferrin
concentrations were found to be critical variables for producing
stable nanovesicle dispersions with diameters ranging from 100 to
200 nm and Zeta potential values of ca. 14.6 mV. The use of these
multiple nanoemulsions in formulating elixirs for oral hygiene
would possess inherent advantages, when compared with the
current chemical antimicrobial formulation, in that lactoferrin is a
naturally harmless protein with bacteriostatic activity, without
toxicological risk even for small children.Acknowledgements
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